Varian Medical Systems, Inc. (VAR)
Stock Price Chart
Key Info
| Market Cap | 15.87B |
| Revenue (ttm) | 3.20B |
| Net Income (ttm) | 263.30M |
| Shares Out | 91.16M |
| EPS (ttm) | 2.94 |
| PE Ratio | 59.22 |
| Forward PE | 32.05 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | November 24 |
| Last Price | $174.12 |
| Previous Close | $173.50 |
| Change ($) | 0.62 |
| Change (%) | 0.36% |
| Day's Open | 174.00 |
| Day's Range | 174.00 - 174.27 |
| Day's Volume | 1,729,388 |
| 52-Week Range | 89.62 - 176.19 |
More Stats
| Market Cap | 15.87B |
| Enterprise Value | 15.79B |
| Earnings Date (est) | Jan 27, 2021 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 91.16M |
| Float | 90.91M |
| EPS (basic) | 2.90 |
| EPS (diluted) | 2.94 |
| FCF / Share | 2.93 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 1.69% |
| FCF Yield | 1.68% |
| Payout Ratio | n/a |
| Shares Short | 2.21M |
| Short Ratio | 1.98 |
| Short % of Float | 2.43% |
| Beta | 1.17 |
| PE Ratio | 59.22 |
| Forward PE | 32.05 |
| P/FCF Ratio | 59.67 |
| PS Ratio | 4.97 |
| PB Ratio | 7.62 |
| Revenue | 3.20B |
| Operating Income | 335.60M |
| Net Income | 263.30M |
| Free Cash Flow | 266.00M |
| Net Cash | 86.60M |
| Net Cash / Share | 0.95 |
| Gross Margin | 43.47% |
| Operating Margin | 10.50% |
| Profit Margin | 8.20% |
| FCF Margin | 8.32% |
| ROA | 6.20% |
| ROE | 13.95% |
| ROIC | 27.20% |
Analyst Forecasts
Analyst Consensus: Hold
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,225 | 2,919 | 2,619 | 2,594 | 2,491 | 3,050 | 2,943 | 2,807 | 2,597 | 2,357 |
| Revenue Growth | 10.48% | 11.45% | 0.99% | 4.14% | -18.33% | 3.63% | 4.84% | 8.1% | 10.19% | - |
| Gross Profit | 1,370 | 1,274 | 1,114 | 1,105 | 1,032 | 1,302 | 1,250 | 1,196 | 1,136 | 1,026 |
| Operating Income | 386 | 437 | 298 | 427 | 396 | 571 | 609 | 594 | 588 | 534 |
| Net Income | 292 | 150 | 219 | 399 | 412 | 404 | 438 | 427 | 399 | 360 |
| Shares Outstanding | 91.00 | 91.50 | 92.50 | 95.40 | 99.70 | 104 | 108 | 111 | 117 | 122 |
| Earnings Per Share | 3.18 | 1.62 | 2.35 | 4.16 | 4.09 | 3.83 | 3.98 | 3.76 | 3.36 | 2.91 |
| EPS Growth | 96.3% | -31.06% | -43.51% | 1.71% | 6.79% | -3.77% | 5.85% | 11.9% | 15.46% | - |
| Operating Cash Flow | 372 | 455 | 399 | 356 | 470 | 449 | 455 | 493 | 473 | 461 |
| Capital Expenditures | -58.00 | -47.70 | -59.10 | -80.40 | -91.40 | -89.60 | -76.28 | -61.10 | -70.93 | -67.55 |
| Free Cash Flow | 314 | 407 | 340 | 276 | 378 | 359 | 379 | 432 | 402 | 393 |
| Cash & Equivalents | 531 | 505 | 716 | 907 | 846 | 915 | 1,181 | 754 | 584 | 520 |
| Total Debt | 410 | - | 350 | 666 | 496 | 438 | 506 | 161 | 198 | 43.39 |
| Net Cash / Debt | 121 | 505 | 366 | 241 | 350 | 478 | 674 | 593 | 386 | 477 |
| Assets | 4,102 | 3,253 | 3,294 | 3,815 | 3,579 | 3,357 | 3,468 | 2,879 | 2,499 | 2,324 |
| Liabilities | 2,324 | 1,664 | 1,773 | 2,060 | 1,852 | 1,741 | 1,755 | 1,369 | 1,255 | 1,049 |
| Book Value | 1,768 | 1,584 | 1,518 | 1,741 | 1,712 | 1,616 | 1,714 | 1,510 | 1,244 | 1,275 |
Company Profile
Company Details
| Full Name | Varian Medical Systems, Inc. |
| Country | United States |
| Employees | 10,000 |
| CEO | Dow R. Wilson |
Stock Information
| Ticker Symbol | VAR |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSE: VAR |
Description
Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.